SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-071176
Filing Date
2019-12-10
Accepted
2019-12-10 07:06:26
Documents
8
Period of Report
2019-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1924813d1_8k.htm 8-K 25805
2 EXHIBIT 1.1 tm1924813d1_ex1-1.htm EX-1.1 259009
3 EXHIBIT 4.1 tm1924813d1_ex4-1.htm EX-4.1 75600
4 EXHIBIT 5.1 tm1924813d1_ex5-1.htm EX-5.1 17190
5 EXHIBIT 99.1 tm1924813d1_ex99-1.htm EX-99.1 11379
6 GRAPHIC tm1924813d1_ex5-1img01.jpg GRAPHIC 1251
7 GRAPHIC tm1924813d1_ex5-1img02.jpg GRAPHIC 7551
8 GRAPHIC tm1924813d1_ex99-1img01.jpg GRAPHIC 15031
  Complete submission text file 0001104659-19-071176.txt   423544
Mailing Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 191276509
SIC: 2834 Pharmaceutical Preparations